Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 1, 2004, Pages 152-159

  Thurman, Sarah A ^a   Schnitt, Stuart J ^a   Connolly, James L ^a   Gelman, Rebecca ^b   Silver, Barbara ^c   Harris, Jay R ^c   Recht, Abram ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer; Medullary; Mucinous; Radiotherapy; Tubular

Indexed keywords

CARCINOGENS; HISTOLOGY; PATIENT MONITORING; PATIENT TREATMENT; RADIOTHERAPY; TUMORS;

FAILURE PATTERNS; INVASION-POSITIVE TUMORS; MALIGNANCY; TUBULAR CARCINOMA;

ONCOLOGY;

TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER INFILTRATION; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HISTOLOGY; HUMAN; INFILTRATING DUCT CARCINOMA; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; PRIORITY JOURNAL; STATISTICAL MODEL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, MEDULLARY; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LOGISTIC MODELS; LYMPH NODE EXCISION; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 16544374251     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.10.029     Document Type: Article

References (18)

1. Surveillance, Epidemiology and End Results cancer statistics review. www.seer.cancer.gov/csr/1973_1999/breast.pdf 1973-1999.
2. Veronesi U., Cascinelli N., Mariani L., et al. Twenty year follow up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 347:2002;1227-1232.
3. Jacobson J., Danforth D., Cowan K., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 332:1995;907-911.
4. Fisher B., Anderson S., Bryant J., et al. Twenty year follow up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy and radiation for the treatment of invasive breast cancer. N Engl J Med. 347:2002;1233-1241.
5. Van Dongen J., Bartelink H., Fentimen I., et al. Randomized clinical trial to assess the value of breast conserving therapy in Stage I and II breast cancer. EORTC 10801. J Nat Cancer Inst. 11:1992;15-18.
6. Northridge M., Rhoads G., Wartenberg D., et al. The importance of histologic type on breast cancer survival. J Clin Epidemiol. 50:1997;283-290.
7. Schnitt S., Connolly J., Recht A., et al. The influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer. 64:1989;448-454.
8. Peiro G., Bornstein B., Connolly J., et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Br Cancer Res Treat. 59:2000;49-54.
9. Gelman R., Gelber R., Henderson C., et al. Improved methodology for analyzing local and distant recurrence. J Clin Oncol. 8:1990;548-555.
10. Winchester D., Sahin A., Tucker S., et al. Tubular carcinoma of the breast Predicting axillary nodal metastasis and recurrence. Ann Surg. 223:1996;342-347.
11. Weiss M., Fowble B., Solin L., et al. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys. 23:1992;941-947.
12. Ellis I.O., Galea M., Locker A., et al. Pathological prognostic factors in breast cancer II. histological type. relationship with survival in a large study with long term follow up. Histopathology. 20:1992;479-489.
13. Diab S., Clark G., Osborne K., et al. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol. 17:1999;1442-1448.
14. Calle R., Vilcoq J., Zafrani B., et al. Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys. 12:1986;873-878.
15. Ribeiro G.G., Magee B., Swindell R., et al. The Christie Hospital breast conservation trial An update at 8 years from inception. Clin Oncol. 5:1993;278-283.
16. Kurtz J., Jacquemier J., Torhorst J., et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer. 63:1989;1630-1635.
17. Ucla L., Fenton J., Mathieu G., et al. Cancers colloides du sein Interet de la radiotherapie: Serie de 138 cas traites a l'Institut Curie. Bull Cancer. 75:1988;783-787.
18. Kitchen P.R.B., Smith J.H., Henderson M.A., et al. Tubular carcinoma of the breast Prognosis and response to adjuvant systemic therapy. ANZ J Surg. 71:2001;27-31.